When the immune system is not in excellent condition, serious diseases can occur in the body. Therefore, storing NK cells at birth is an investment in the health of your children and of compatible family members.
It is possible to store them both for autologous use (i.e. by the same individual from which they were taken) and for haploidentical use (i.e. by relatives compatible to 50%). Infusion of haploidentical NK cells is a safe practice.
The unique characteristics of NK cells make them an ideal weapon for cancer immunotherapy approaches. Several scientific studies have shown both their anticancer efficacy and their safety. Their use is not associated with rejection and, compared to other therapies, reduces the risk of relapse.
NK cells from umbilical cord blood have been shown to be fully effective in the case of leukemia. Furthermore, numerous experimental studies have shown the possibility of modifying NK cells and stimulating their proliferation in such a way as to increase their efficacy against cancer.
Multiple doses of NK cells can be obtained from a single umbilical cord blood sample for use in immunotherapy.
Cord blood is the blood that remains in the umbilical cord after the baby is born and is a valuable source of stem cells.
Until recently it was treated as “waste” and eliminated with hospital waste along with the placenta and the umbilical cord. It is currently used in the treatment of around 100 serious diseases.
